No validated clinical test exists for diagnosing “leaky gut syndrome,” and the condition itself is not recognized as a formal medical diagnosis by mainstream gastroenterology. That said, researchers do have tools for measuring intestinal permeability in controlled settings, most notably the lactulose-mannitol ratio test. The gap between what science can measure in a lab and what a doctor can order for you in a clinic is wide, and it is exactly where confusion thrives.
Leaky Gut Is a Real Phenomenon, Not a Recognized Diagnosis
The intestinal lining is not a solid wall. It is a single layer of cells held together by structures called tight junctions, which act as selective gatekeepers between what stays inside your gut and what enters your bloodstream. Proteins like claudins and occludin form the backbone of these junctions, sealing the spaces between neighboring cells while still allowing nutrients through.1PubMed Central. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases When those junctions loosen up more than they should, larger molecules can slip through the gaps. Researchers call this increased intestinal permeability. The popular term “leaky gut” describes the same thing, but it carries baggage: it is widely promoted in wellness culture as a root cause of everything from brain fog to autoimmune disease, and that framing outpaces the evidence.
The core issue is that increased intestinal permeability is a measurable physiological event, but “leaky gut syndrome” as a standalone diagnosis does not appear in standard medical textbooks or diagnostic codes.2PubMed Central. Leaky Gut Syndrome: Myths and Management Patients are sometimes told that blood work or stool tests can readily confirm the diagnosis, but that claim does not hold up. This does not mean the phenomenon is imaginary. Increased permeability has been documented in celiac disease, Crohn’s disease, and other conditions. The problem is the leap from “permeability can change” to “we can diagnose a discrete syndrome from a single test.”
The Lactulose-Mannitol Test
The closest thing researchers have to a gold standard for measuring gut permeability is the dual-sugar test, most often using lactulose and mannitol. You drink a solution containing both sugars, then collect your urine over several hours. Mannitol is small enough to pass through the intestinal lining easily, giving a baseline measure of absorption. Lactulose is larger and normally does not cross the barrier in significant amounts. If lactulose shows up in higher-than-expected quantities relative to mannitol, it suggests the junctions between cells are letting more through than usual.
A meta-analysis pooling data from studies of celiac and Crohn’s disease found that healthy controls had a pooled lactulose-to-mannitol ratio of about 0.014, while people with untreated celiac disease had a ratio around 0.133 and those with active Crohn’s disease came in near 0.093.3PubMed Central. A case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose:mannitol ratio in coeliac and Crohn’s disease Those are meaningful differences, and they show the test can distinguish between healthy guts and guts with known diseases. But the test has real limitations. The timing of urine collection matters: research suggests that the window between roughly two and a half to four hours after drinking the sugar solution gives the most reliable read on small-intestine permeability.4PubMed Central. Standardising the Lactulose Mannitol Test of Gut Permeability to Minimise Error and Promote Comparability Collect too early or too late and you start picking up colonic permeability, which muddies the picture.5PubMed Central. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion
Despite decades of use in research, the lactulose-mannitol test is not standardized for clinical diagnosis. There is no universally agreed-upon cutoff ratio that means “you have leaky gut.” Different labs use different protocols, different collection windows, and different reference ranges. The test works well for comparing groups in a study. It works less well for telling an individual patient whether their gut is leakier than it should be.
The Zonulin Testing Problem
If you have looked into leaky gut testing online, you have almost certainly seen zonulin mentioned. Zonulin is a protein involved in regulating tight junction permeability, and blood tests for it are widely marketed by functional medicine labs as a way to detect increased intestinal permeability. The pitch is straightforward: high zonulin means leaky gut.
The reality is messier. A detailed investigation published in the journal Gut found that commercially available zonulin blood tests do not actually measure zonulin. The antibodies used in these kits cross-react with structurally similar proteins, meaning the number you get back reflects the concentration of unknown proteins rather than zonulin itself.6PubMed Central. Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability To make matters worse, results from these commercial tests correlate poorly with permeability as measured by the lactulose-mannitol method. So even if high zonulin levels did reliably indicate a leaky gut, the kits being sold are not reliably measuring zonulin in the first place.
Researchers who identified this problem found that people who genetically should not produce zonulin at all still registered positive on commercial tests, confirming that the kits were detecting something else entirely.7PubMed Central. An Association Between the Intestinal Permeability Biomarker Zonulin and the Development of Diabetic Retinopathy in Type II Diabetes Mellitus This does not mean zonulin is irrelevant to gut permeability. It likely plays a role in conditions like celiac disease, where the protein gliadin triggers a cascade that weakens tight junctions partly through zonulin-related mechanisms.8Brazilian Journal of Medical and Biological Research. Gut permeability to lactulose and mannitol differs in treated Crohn’s disease and celiac disease patients and healthy subjects But a commercial blood test telling you your zonulin is elevated is not giving you the information it claims to give.
Other Approaches That Exist but Are Not Standard
Researchers have experimented with several other methods for gauging intestinal permeability, each with its own trade-offs.
- PEG probes: Polyethylene glycol molecules of various sizes can be swallowed and then measured in urine, similar to the dual-sugar test. Some studies have found that PEG probes can detect drug-induced permeability changes, particularly within the first two hours after ingestion.9PubMed Central. Polyethylene glycol versus dual sugar assay for gastrointestinal permeability analysis: is it time to choose? However, earlier research raised concerns that PEG molecules in certain size ranges may cross the intestinal lining through mechanisms unrelated to tight junctions, limiting their usefulness as a pure permeability marker.10PubMed. Gastrointestinal permeability to polyethylene glycol: an evaluation of urinary recovery of an oral load of polyethylene glycol as a parameter of intestinal permeability in man
- Ussing chambers: These are lab devices that mount a small piece of intestinal tissue (from a biopsy) between two compartments and measure how easily molecules and electrical current pass through it. They are the most direct way to measure permeability, but they require a tissue sample, sophisticated lab equipment, and skilled technicians. They are a research tool, not something your doctor will casually order.11PubMed Central. The Ussing chamber system for measuring intestinal permeability in health and disease
- Blood biomarkers: Some labs test for antibodies against lipopolysaccharide (LPS) or occludin, both of which are associated with barrier breakdown. One study found positive associations between these antibodies and IgG-mediated food sensitivities, suggesting they might flag people whose guts are letting more through than normal.12PubMed Central. Associations between food-specific IgG antibodies and intestinal permeability biomarkers But like zonulin testing, these biomarkers have not been validated in large clinical trials as diagnostic tools for a specific condition.
The common thread is that all of these methods can detect something real, but none has been turned into a standardized, clinically validated diagnostic test with agreed-upon cutoffs and clear implications for treatment.
Why Your Doctor Probably Will Not Test for It
Gastroenterologists are not being stubborn when they decline to test for leaky gut. The problem is practical. Even if a test showed your intestinal permeability was elevated, the finding alone would not tell you why it is elevated, and it would not clearly point toward a specific treatment. Increased permeability is associated with a long list of conditions, from inflammatory bowel disease to type 2 diabetes to liver disease. Testing for it without already suspecting a specific underlying disease is a bit like measuring someone’s body temperature without any other context: a fever tells you something is wrong, but not what.
When permeability testing does happen in clinical settings, it is almost always in the context of a known disease. Celiac disease researchers use the lactulose-mannitol test to track how well patients respond to a gluten-free diet. Crohn’s disease researchers use it to detect early signs of relapse. In these situations the test has a clear purpose: monitoring a diagnosed condition, not discovering a new one.
What Actually Increases Intestinal Permeability
Though you cannot easily test for it in a clinic, the factors that loosen tight junctions are well documented in research. Understanding them is arguably more useful than chasing a test result, because many are modifiable.
Nonsteroidal anti-inflammatory drugs like ibuprofen and aspirin are among the best-studied culprits. These drugs undergo a recycling process between the liver and the intestine that repeatedly exposes the gut lining to the drug and its breakdown products, gradually weakening the barrier.13PubMed Central. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease In one study, five days of indomethacin (a potent NSAID) tripled gut permeability as measured by the lactulose-rhamnose ratio.14PubMed Central. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes
Prolonged intense exercise is another trigger. Research shows that roughly 60 minutes of vigorous endurance training at about 70% of maximum capacity can produce the characteristic signs of increased permeability.15PubMed Central. Is There an Exercise-Intensity Threshold Capable of Avoiding the Leaky Gut? The mechanism appears to involve oxidative stress. Animal studies have found that high-intensity exercise reduces levels of the tight-junction protein claudin-1 in the gut and that blocking a key oxidative enzyme prevents the permeability increase.16PubMed Central. High-intensity exercise impairs intestinal barrier function by generating oxidative stress This does not mean exercise is bad for your gut overall, but it does explain why marathon runners and ultra-endurance athletes frequently deal with gastrointestinal distress during and after events.
When the gut barrier loosens, bacterial components like lipopolysaccharide (LPS) can enter the bloodstream. This triggers an immune response that produces low-grade inflammation throughout the body, a process researchers call metabolic endotoxemia.17PubMed Central. Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions Diet plays a role here too, because the bacteria living in your gut produce short-chain fatty acids that help strengthen the intestinal barrier and reduce inflammation. When microbial communities shift in unfavorable directions, that protective effect weakens.18PubMed Central. Role of short chain fatty acids in gut health and possible therapeutic approaches in inflammatory bowel diseases
Supplements That Show Early Promise
Because you cannot easily get a test that tells you exactly how leaky your gut is, the practical question for most people shifts to: what can I do about it anyway? A handful of supplements have shown effects on permeability markers in small studies, though none has the weight of evidence behind it that would make a gastroenterologist confidently prescribe it.
Zinc carnosine has probably the most interesting data. In a human trial, volunteers who took zinc carnosine alongside indomethacin (the NSAID that tripled permeability in the control group) showed no significant increase in permeability at all.14PubMed Central. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes That is a striking protective effect, though the study was small and conducted under specific conditions.
Glutamine has been tested in several exercise-related studies, mostly in hot environments where gut stress is amplified. A systematic review found that three out of four studies showed lower markers of gut damage after running in people who took glutamine beforehand, and both acute and chronic supplementation reduced permeability as measured by the lactulose-rhamnose ratio.19PLOS ONE. A systematic review: Role of dietary supplements on markers of exercise-associated gut damage and permeability Bovine colostrum has also been examined across multiple small trials. The same review noted a blunting effect on markers of gut-lining damage during moderate-temperature exercise, and when colostrum was combined with zinc carnosine, permeability measures dropped substantially compared to placebo.19PLOS ONE. A systematic review: Role of dietary supplements on markers of exercise-associated gut damage and permeability
These results are encouraging but modest. The studies are small, often done in athletes under heat stress, and the endpoints vary from study to study. Anyone selling these supplements as a proven “leaky gut cure” is running ahead of the evidence. But for people who regularly take NSAIDs or do intense endurance exercise, the data is interesting enough to discuss with a doctor.
A Drug Being Developed Specifically for Tight Junctions
Larazotide acetate is a small peptide that acts directly on tight junctions, and it represents one of the first serious pharmaceutical attempts to treat increased intestinal permeability as a target in its own right. The drug was designed to prevent tight junctions from opening when they are triggered by gliadin, the protein in gluten that causes problems in celiac disease.20PubMed Central. Larazotide acetate: a pharmacological peptide approach to tight junction regulation
In a randomized, double-blind trial, researchers challenged celiac patients with gluten while giving some of them larazotide. The drug did not reliably reduce the lactulose-mannitol ratio under real-world outpatient conditions, where day-to-day variability in the test was too large to detect a clear signal. However, some doses did appear to prevent the increase in gastrointestinal symptoms that gluten normally triggers.21PubMed Central. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge Lab studies have shown more clearly how the drug works: it keeps a key structural protein from being activated in a way that would pull tight junctions apart, and it preserves tight junction organization during injury.22PubMed Central. Larazotide Acetate Protects the Intestinal Mucosal Barrier from Anoxia/Reoxygenation Injury via Various Cellular Mechanisms The drug has reached phase III clinical trials, making it the furthest along of any permeability-targeted therapy.
Larazotide is worth knowing about because it signals a shift in how mainstream medicine might eventually handle increased permeability. If a drug can specifically tighten gut junctions, the need for a validated diagnostic test to identify who would benefit becomes more pressing. The two problems, testing and treatment, are likely to mature together.
Aging and the Gut Barrier
One factor that rarely comes up in popular discussions of leaky gut is age. A study comparing healthy older adults with younger adults found that serum markers associated with intestinal permeability were significantly higher in the older group.23PubMed Central. Intestinal Permeability Biomarker Zonulin is Elevated in Healthy Aging This was in people without diagnosed gastrointestinal conditions, suggesting that some degree of barrier loosening may simply accompany normal aging.
This finding complicates the narrative in both directions. For the wellness industry, it means that elevated permeability biomarkers in a middle-aged person might just reflect age rather than a disease state, making it even harder to draw diagnostic lines. For conventional medicine, it raises the question of whether age-related barrier weakening contributes to the chronic low-grade inflammation that characterizes getting older, and whether interventions targeting the gut lining could have broader health benefits. Neither side has definitive answers yet, which is itself a useful thing to know when someone tries to sell you certainty in either direction.